Moscow [Russia], November 24 (ANI): The developers of Sputnik V coronavirus vaccine announced on Tuesday that it had an efficacy rate or 95 per cent based on the second interim analysis of clinical data.
Moscow [Russia], September 7 (ANI): The clinical trials of Sputnik V vaccine for coronavirus will be held this month in several countries including India, confirmed Kirill Dmitriev, CEO of the Russian Direct Investment Fund (RDIF) on Monday.
New Delhi [India], September 4 (ANI): Russia is in close dialogue with the Indian government and the leading drug manufactures of India regarding the localization of production of Sputnik V vaccine in India, said Kirill Dmitriev, CEO of the Russian Direct Investment Fund (RDIF) on Friday.